Can serum biomarker assays measure the progression of cartilage degeneration in osteoarthritis?

Arthritis and Rheumatism

Volumn 46, Issue 10, 2002, Pages 2549-2552

  Poole, A Robin ^a,b,c  

^a Human Disease Markers Inc   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGENASE; COLLAGENASE 3;

AGING; BIOASSAY; BLOOD ANALYSIS; BONE MATRIX; BONE METABOLISM; BONE TURNOVER; CALCIFICATION; CARTILAGE DEGENERATION; CELL DEGENERATION; CELL GROWTH; COLLAGEN SYNTHESIS; CROSS LINKING; DISEASE COURSE; DISEASE SEVERITY; EDITORIAL; HUMAN; NONHUMAN; OSTEOARTHRITIS; OSTEOLYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION;

BIOLOGICAL MARKERS; CARTILAGE; DISEASE PROGRESSION; HUMANS; OSTEOARTHRITIS;

EID: 0036822673     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10586     Document Type: Editorial

References (26)

1. Poole AR. Cartilage in health and disease. In: Koopman W, editor. Arthritis and allied conditions: a textbook of rheumatology. 14th ed. Philadelphia: Lippincott, Williams & Wilkins; 2000. p. 226-84.
2. Poole AR, Howell DS. Etiopathogenesis of osteoarthritis. In: Moskowitz RW, Howell DS, Goldberg VM, Mankin HJ, editors. Osteoarthritis: diagnosis and management. 3rd ed. Philadelphia: WB Saunders; 2001. p. 29-47.
3. Neuhold LA, Killar L, Zhao W, Sung, M-LA, Warner L, Kulik J, et al. Osteoarthritis develops in transgenic mice expressing constitutively active human collagenase-3 (MMP-13) in articular cartilage. J Clin Invest 2001;107:35-44.
4. Aurich M, Poole AR, Reiner A, Mollenhauer C, Margulis A, Kuettner KE, et al. Matrix homeostasis in aging normal human ankle cartilage. Arthritis Rheum. In press.
5. Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest 1997;99:1534-45.
6. Hollander AP, Heathfield TF, Webber C, Iwata Y, Bourne R, Rorabeck C, et al. Increased damage to type II collagen in osteoarthritic articular cartilage detected by a new immunoassay. J Clin Invest 1994;93:1722-32.
7. Lark MW, Bayne EK, Flanagan J, Harper CF, Hoerrner LA, Hutchinson NI, et al. Aggrecan degradation in human cartilage: evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritis, and rheumatoid joints. J Clin Invest 1997;100:93-106.
8. Wu W, Billinghurst RC, Pidoux I, Antoniou J, Zukor D, Tanzer M, et al. Sites of collagenase cleavage and denaturation of type II collagen in aging and osteoarthritic articular cartilage and their relationship to the distribution of matrix metalloproteinase 1 and matrix metalloproteinase 13. Arthritis Rheum 2002;46:2087-94.
9. Hollander AP, Pidoux I, Reiner A, Rorabeck C, Bourne R, Poole AR. Damage to type II collagen in aging and osteoarthritis starts at the articular surface, originates around chondrocytes, and extends into the cartilage with progressive degeneration. J Clin Invest 1995;96:2859-69.
10. Mankin HJ, Lippiello P. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic human hips. J Bone Joint Surg Am 1970;52:424-34.
11. Nelson F, Dahlberg L, Laverty S, Reiner A, Pidoux I, Ionescu M, et al. Evidence for altered synthesis of type II collagen in patients with osteoarthritis. J Clin Invest 1998;102:2115-25.
12. Rizkalla G, Reiner A, Bogoch E, Poole AR. Studies of the articular cartilage proteoglycan aggrecan in health and osteoarthritis: evidence for molecular heterogeneity and extensive molecular changes in disease. J Clin Invest 1992;90:2268-77.
13. Aigner T, Zhu Y, Chansky HH, Matsen FA III, Maloney WJ, Sandell LJ. Reexpression of type IIA procollagen by adult articular chondrocytes in osteoarthritic cartilage. Arthritis Rheum 1999;42:1443-50.
14. Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, et al. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum 2000;43:673-82.
15. Poole AR, Rosenberg LC, Reiner A, Ionescu M, Bogoch E, Roughley PJ. Contents and distributions of the proteoglycans decorin and biglycan in normal and osteoarthritic human articular cartilage. J Orthop Res 1996;14:681-9.
16. Poole AR. NIH White Paper: Biomarkers, the osteoarthritis initiative. Bethesda (MD): National Institutes of Health, NIAMS News and Events; 2000. URL: www.nih.gov/niams/news/oisg.
17. Delmas PD, Garnero P. Biological markers of bone turnover in osteoporosis. In: Stevenson JC, Lindsay R, editors. Osteoporosis. London: Chapman and Hall; 1998. p. 117-36.
18. Kojima T, Mwale F, Yasuda T, Girard C, Poole AR, Laverty S. Early degradation of type IX and type II collagen with the onset of experimental inflammatory arthritis. Arthritis Rheum 2001;44:120-7.
19. Downs JT, Lane CL, Nester NB, McLellan TJ, Kelly MA, Karam GA, et al. Analysis of collagenase-cleavage of type II collagen using a neoepitope ELISA. J Immunol Methods 2001;247:25-34.
20. Christgau S, Garnero P, Fledelius C, Moniz C, Ensig M, Gineyts E, et al. Collagen type II C-telopeptide fragments as an index of cartilage degradation. Bone 2001;29:209-15.
21. Lohmander LS, Atley LM, Pietka TA, Eyre DR. The release of cross-linked peptides from type II collagen into joint fluid and serum is increased in osteoarthritis and after joint injury. Trans Orthop Res Soc 2000;25:236.
22. Lohmander LS, Poole AR. Defining and validating the clinical role of molecular markers in osteoarthritis. In: Brandt K, Lohmander LS, Doherty M, editors. Osteoarthritis. 2nd ed. Oxford: Oxford University Press. In press.
23. Garnero P, Ayral X, Rousseau J-C, Christgau S, Sandell LJ, Dougados M, et al. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis. Arthritis Rheum 2002;46:2613-24.
24. Oganesian A, Zhu Y, Sandell LJ. Type IIA procollagen amino propeptide is localized in human embryonic tissues. J Histochem Cytochem 1997;45:1469-80.
25. Lui VC, Ng LJ, Nicholls J, Tam PP, Cheah KS. Tissue-specific and differential expression of alternatively spliced alpha 1 (II) collagen mRNAs in early human embryos. Dev Dyn 1995;203:198-211.
26. Dequeker J, Mohan S, Finkelman RD, Aerssens J, Baylink DJ. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor β in cortical bone from the iliac crest: possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum 1993;36:1702-8.